STAGE IV BREAST CANCER
Clinical trials for STAGE IV BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IV BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine aims to train immune system against breast cancer stem cells
⭐️ VACCINE ⭐️ OngoingThis early-phase trial tests a DNA vaccine called STEMVAC in 42 people with advanced HER2-negative breast cancer. The vaccine is designed to help the immune system recognize and attack cancer stem cells, which are often resistant to standard treatments. The main goals are to chec…
Matched conditions: STAGE IV BREAST CANCER
Phase: PHASE1 • Sponsor: University of Washington • Aim: ⭐️ VACCINE ⭐️
Last updated May 20, 2026 11:57 UTC
-
New hope for hard-to-treat breast cancer: immune-boosting combo trial underway
Disease control OngoingThis study tests whether combining the immunotherapy drug avelumab with other medications can help people with advanced triple-negative breast cancer. About 145 adults with stage IV or inoperable breast cancer will receive one of several drug combinations. The goal is to see if t…
Matched conditions: STAGE IV BREAST CANCER
Phase: PHASE2 • Sponsor: Laura Huppert, MD, BA • Aim: Disease control
Last updated May 26, 2026 03:15 UTC
-
New drug aims to extend life for hard-to-treat breast cancer patients
Disease control OngoingThis study tests whether the drug sacituzumab govitecan can help people with a common type of advanced breast cancer (HR+/HER2-) live longer without their cancer growing, compared to standard chemotherapy. About 654 participants who have already tried hormone therapy will receive…
Matched conditions: STAGE IV BREAST CANCER
Phase: PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New PET scan may predict breast cancer drug success
Diagnosis OngoingThis study tests whether a special PET scan can predict if the drug T-DM1 will work in people with advanced HER2-positive breast cancer that has spread. Ten women with metastatic breast cancer received a radioactive tracer to see where the drug goes in the body. The goal is to he…
Matched conditions: STAGE IV BREAST CANCER
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 26, 2026 03:12 UTC
-
New imaging agent lights up breast cancer tumors for better treatment planning
Diagnosis OngoingThis study tested a special PET scan that uses a radioactive tracer (64Cu-DOTA-trastuzumab) to find HER2-positive breast cancer tumors in women with advanced stage IV disease. The goal was to see if the scan could tell the difference between HER2-positive and HER2-negative tumors…
Matched conditions: STAGE IV BREAST CANCER
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 26, 2026 02:48 UTC